BioSpace News Archive

Biocon Biologics, a fully integrated ‘pure play’ global biosimilars organisation, brought together Key Opinion Leaders (KOLs), including physicians, scientists, healthcare professionals, government representatives, policy makers, and IDF members, at its symposium on ‘100 years of Insulin – Delivering on Universal Access & Equitable Care’ held during the IDF Congress 2019, at Busan, South Korea.

GenEdit has developed a comprehensive delivery system for CRISPR-based therapeutics, including gene knockout and gene repair therapies, to enable safer delivery options with improved efficiency.

People who use eHealth’s online health plan comparison tool are twice as likely to enroll

Investigational KTE-X19 To Be First Chimeric Antigen Receptor (CAR) T Cell Therapy for Mantle Cell Lymphoma if Approved

On December 2, 2019, Jubilant DraxImage Inc. and certain of its affiliates received notice of the favorable decision of the U.S. International Trade Commission in its case against Bracco Diagnostics Inc.

Danaher will deliver 5.5784 shares of Envista common stock to or at the direction of any such tendering stockholder.

In addition, the Company has granted the Purchasers and certain finders an aggregate of 2,693,573 three-year warrants to purchase up to an additional 2,693,573 ordinary shares at an exercise price between $2.37 and $2.96 per share

SQI is a Toronto-based life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced multiplexed diagnostics.

Eviti Connect study showed an increase in clinical uptake of practice-changing data

A copy of this poster presentation is available on the Puma website